Abstract:Nuclear factor (NF)-kappaB transcription factors are involved in the control of a large number of normal cellular and organismal processes, such as immune and inflammatory responses, developmental processes, cellular growth, and apoptosis. Transcription of the human immunodeficiency virus type 1 (HIV-1) genome depends on the intracellular environment where the integrate viral DNA is regulated by a complex interplay among viral regulatory proteins, such as Tat, and host cellular transcription factors, such as NF-kappaB, interacting with the viral long terminal repeat region. CBP (CREB-binding protein) and p300, containing an intrinsic histone acetyltransferase (HAT) activity, have emerged as coactivators for various DNA-binding transcription factors. Here, we show that the p50 subunit as well as the p50/p65 of NF-kappaB, and not other factors such as SP1, TFIIB, polymerase II, TFIIA, or p65, can be acetylated by CBP/p300 HAT domain. Acetylation of p50 was completely dependent on the presence of both HAT domain and Tat proteins, implying that Tat influences the transcription machinery by aiding CBP/p300 to acquire new partners and increase its functional repertoire. Three lysines, Lys-431, Lys-440, and Lys-441 in p50 were all acetylated an vitro, and a sequence similarity among p50, p53, Tat, and activin receptor type I on these particular lysines was observed. All proteins have been shown to be acetylated by the CBP/p300 HAT domain. Acetylated p50 increases its DNA binding properties, as evident by streptavidin/biotin pull-down assays when using labeled NF-kappaB oligonucleotides. Increased DNA binding on HIV-1 long terminal repeat coincided with increases in the rate of transcription. Therefore, we propose that acetylation of the DNA binding domain of NF-kappaB aids in nuclear translocation and enhanced transcription and also suggest that the substrate specificity of CBP/p300 can be altered by small peptide molecules, such as HIV-encoded Tat.

Tat acetylation regulates its actions on microtubule dynamics and apoptosis in T lymphocytes.

Modulation of Eg5 Activity Contributes to Mitotic Spindle Checkpoint Activation and Tat-Mediated Apoptosis in Cd4-Positive T-Lymphocytes

Systematic Analysis of the Functions of Lysine Acetylation in the Regulation of Tat Activity.

Regulation of Tat Acetylation and Transactivation Activity by the Microtubule-Associated Deacetylase Hdac6

Hiv-1 Tat Transcriptional Activity is Regulated by Acetylation

Killing HIV-infected Resting Central Memory CD4+ T Cells by Targeting Inhibitor of Apoptosis Proteins-Inhibited Autophagy

Modulation of the Stability and Activities of HIV-1 Tat by Its Ubiquitination and Carboxyl-Terminal Region.

HIV-1 Tat Activates Akt/mTORC1 Pathway and AICDA Expression by Downregulating Its Transcriptional Inhibitors in B Cells

Tat-induced FOXO3a is a key mediator of apoptosis in HIV-1-infected human CD4+ T lymphocytes

Enhancement of Nuclear Factor-κB Acetylation by Coactivator P300 and HIV-1 Tat Proteins

HIV Tat Binds Egr Proteins and Enhances Egr-dependent Transactivation of the Fas Ligand Promoter

VDAC Upregulation and Αtat1‑mediated Α‑tubulin Acetylation Contribute to Tanespimycin‑induced Apoptosis in Calu‑1 Cells.

Heterogenic Bcl-Xs Fused with Tat Basic Domain Can Induce Programmed Cell Death after Transient Incubation

Tat-interactive Protein-60KDA (TIP60) Regulates the Tumorigenesis of Lung Cancer In Vitro.

Regulation of Histone Acetyltransferase TIP60 Function by Histone Deacetylase 3

Immune Regulator Abin1 Suppresses Hiv-1 Transcription by Negatively Regulating the Ubiquitination of Tat

The TAR Binding Dynamics and Its Implication in Tat Degradation Mechanism

TIP 30 has an intrinsic kinase activity required for up-regulation of a subset of apoptotic genes molecular mechanism by which the CC 3 gene mediates

Tat Competes with HEXIM1 to Increase the Active Pool of P-TEFb for HIV-1 Transcription

Combined Metabonomic and Quantitative Real-Time Pcr Analyses Reveal Systems Metabolic Changes in Jurkat T-Cells Treated with Hiv-1 Tat Protein

Human immunodeficiency virus type 1 Tat accelerates Kaposi sarcoma-associated herpesvirus Kaposin A-mediated tumorigenesis of transformed fibroblasts in vitro as well as in nude and immunocompetent mice.